The Oxygen and Carbon Monoxide Reactions of Heme Oxygenase*

Catharina Taiko MigitaDagger , Kathryn Mansfield Matera§, and Masao Ikeda-Saito

From the Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-4970

John S. Olson

From the Department of Biochemistry and Cell Biology and W. M. Keck Center for Computational Biology, Rice University, Houston, Texas 77005-1892

Hiroshi Fujii, and Tetsuhiko Yoshimura

From the Institute for Life Support Technology, Yamagata Technopolis Foundation, Yamagata 990, Japan

Hong Zhou, and Tadashi Yoshida

From the Department of Biochemistry, Yamagata University School of Medicine, Yamagata 990-23, Japan

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The O2 and CO reactions with the heme, alpha -hydroxyheme, and verdoheme complexes of heme oxygenase have been studied. The heme complexes of heme oxygenase isoforms-1 and -2 have similar O2 and CO binding properties. The O2 affinities are very high, KO2 = 30-80 µM-1, which is 30-90-fold greater than those of mammalian myoglobins. The O2 association rate constants are similar to those for myoglobins (kO2' = 7-20 µM-1 s-1), whereas the O2 dissociation rates are remarkably slow (kO2 = 0.25 s-1), implying the presence of very favorable interactions between bound O2 and protein residues in the heme pocket. The CO affinities estimated for both isoforms are only 1-6-fold higher than the corresponding O2 affinities. Thus, heme oxygenase discriminates much more strongly against CO binding than either myoglobin or hemoglobin. The CO binding reactions with the ferrous alpha -hydroxyheme complex are similar to those of the protoheme complex, and hydroxylation at the alpha -meso position does not appear to affect the reactivity of the iron atom. In contrast, the CO affinities of the verdoheme complexes are >10,000 times weaker than those of the heme complexes because of a 100-fold slower association rate constant (kCO'   approx  0.004 µM-1 s-1) and a 300-fold greater dissociation rate constant (kCO approx  3 s-1) compared with the corresponding rate constants of the protoheme and alpha -hydroxyheme complexes. The positive charge on the verdoporphyrin ring causes a large decrease in reactivity of the iron.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Heme oxygenase (HO)1 is an amphipathic microsomal protein that catalyzes the regiospecific oxidative degradation of iron protoporphyrin IX (heme hereafter) to biliverdin, CO, and iron in the presence of NADPH-cytochrome P-450 reductase as an electron donor (1-3). In the catalytic cycle the enzyme first binds 1 equivalent of hemin. This binding results in the formation of the heme-enzyme complex, which exhibits spectral properties similar to those of ferric myoglobins and hemoglobins (4, 5). The first electron donated from the reductase reduces the hemin iron to the ferrous state, and then O2 binds rapidly to form a metastable oxy complex (6). Electron donation to the oxy form initiates the three-step conversion of oxyheme to the ferric iron-biliverdin complex through alpha -hydroxyheme and verdoheme intermediates (Scheme 1). The final step involves electron donation from the reductase to convert the ferric iron-biliverdin complex to ferrous iron and biliverdin (7). Thus, heme participates both as a prosthetic group and as a substrate, a property unique to heme oxygenase (5, 7).


View larger version (24K):
[in this window]
[in a new window]
 
Scheme 1.   Intermediates in the reaction of the heme-oxygenase-catalyzed conversion of iron protoporphyrin IX to the biliverdin-iron complex.

HO has two isoforms, referred to as HO-1 and HO-2 (3). HO-1, an inducible form with a molecular mass of 33 kDa, is distributed mainly in reticuloendothelial cell-rich tissues such as spleen and liver. HO-2, with a molecular mass of 36 kDa, is expressed constitutively and is distributed mainly in the brain and testis. The amino acid sequence similarity between HO-1 and HO-2 is about 40%. However, both isoforms display the same enzymatic activity, active site structure, and heme iron coordination and electronic structures, hence the molecular mechanism of enzyme action is considered to be analogous between the two isoforms (8).

We and others have demonstrated that a neutral form of the imidazole group of histidine (His25 in the HO isoform-1 sequence) is the axial heme ligand in the heme-enzyme complex of the water-soluble forms of recombinant HO (9-12). Although the distal residues have yet to be identified (13), an ionizable group with a pKa value of 7.6 is linked to the water molecule, which is coordinated to the ferric heme-HO-1 complex (9). The heme-HO complex appears to have an axial ligand coordination structure that is similar to that in myoglobins and hemoglobins. Resonance Raman studies on the oxy form of the heme-HO complex show that the bound oxygen molecule assumes a highly bent configuration because of strong interactions with the residues in the distal pocket (14). The CO-bound verdoheme-HO complex exhibits a Fe-CO stretching frequency at 470 cm-1 which is much lower than the Fe-CO ~505 cm-1 stretching frequency of the heme- and alpha -hydroxyheme-HO complexes (15). The Fe-CO bond in the verdoheme complex appears to be quite different and weaker than that in either the heme or alpha -hydroxyheme complex.

During catalysis, CO is formed when alpha -hydroxyheme is converted to verdoheme (16). CO binds to ferrous forms of the heme-, alpha -hydroxyheme-, and verdoheme-HO complexes (4, 10, 15, 17). Generally, CO binds to ferrous heme iron with a higher affinity than O2 does. Hence, CO generated during the verdoheme formation can coordinate to either heme or verdoheme resulting in product inhibition, and Noguchi et al. (18) have shown that CO can inhibit the HO enzyme activity by binding to either the ferrous heme- and verdoheme-HO complexes. Yoshida and his co-workers (19) have demonstrated that when a single turnover enzyme reaction is carried out using an 80% air and 20% CO gas mixture, the CO complex of the verdoheme-HO is generated. This shows that in the presence of 80% air, 20% CO does not completely inhibit the first two mono-oxygenase cycles of HO catalysis, but the conversion of verdoheme to biliverdin may be inhibited. However, a quantitative assessment of CO inhibition requires accurate determinations of the O2 and CO affinities of the ferrous heme-HO complex. A low CO affinity was reported for verdoheme-myoglobin (20), but the affinity of verdoheme-HO for CO has not been determined.

To this end, we have examined the reactions of O2 and CO with the heme, alpha -hydroxyheme, and verdoheme complexes of heme oxygenase. The heme-HO complex has an extremely high O2 affinity because of a very slow O2 dissociation reaction. However, the CO affinities of the heme and alpha -hydroxyheme complexes are very similar to those of mammalian myoglobins and hemoglobins. In contrast, the verdoheme-HO complexes have extraordinary low affinities for CO. We attribute the low CO affinity of the verdoheme-HO complex to the partial ferric character of the verdoheme iron atom. The high O2 affinity of the heme-HO complex and the low CO affinity of the verdoheme-HO effectively prevent product inhibition by CO that is generated during catalysis of hemin degradation.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Truncated water-soluble forms of recombinant rat HO-1 (30 kDa) and human HO-2 (28 kDa) and the corresponding heme, alpha -hydroxyheme, and verdoheme complexes were prepared as described previously (8, 11, 14, 15, 17).

The CO forms of the heme-, alpha -hydroxyheme-, and verdoheme-HO complexes were prepared by diluting the ferrous forms of the complexes into the anaerobic buffer solutions containing known CO concentrations. The oxy form of the heme-HO complexes was made as follows. First, the ferric heme-HO complex was reduced by sodium dithionite in deoxygenated buffer. Then the reduced form of the complex was passed through a column of Sephadex G-25 equilibrated with buffer containing the known O2 concentrations. Formation of the complex was confirmed by optical absorption measurements.

O2 and CO binding reactions were measured using stopped-flow and flash photolysis techniques as described previously (21). The sample integrity was confirmed by the optical absorption spectra measured before and after the flash photolysis measurements. All the measurements were carried out in 0.1 M phosphate buffer, pH 7, at 20 °C.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The association and dissociation rate constants for O2 and CO binding to ferrous forms of the heme-HO-1 and HO-2 complexes are listed in Table I. The kinetic traces for bimolecular rebinding of O2 to the heme-HO complex after flash photolysis are monophasic, and the observed rates depend linearly on O2 concentration (Fig. 1). The association rate constants, k'O2, are similar to those of mammalian myoglobins. However, the O2 dissociation rate constants, kO2, of the heme-HO complexes are ~0.25 s-1, about 100 times slower than the dissociation rat constants of myoglobins (15 s-1) (22). The O2 equilibrium constants, KO2, are 28 and 77 µM-1 for the HO-1 and HO-2 complexes, respectively, 30-90 times greater than the equilibrium constant of myoglobin. The O2 affinity of the heme-HO complexes is equal to or higher than that of leghemoglobin, which has one of the highest known O2 affinities.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Parameters for O2 and CO binding to the heme-HO complexes, human myoglobin, and leghemoglobin in 0.1 M phosphate buffer, pH 7, 20 °C
Data for myoglobin and leghemoglobin are taken from Springer et al. (22) and Hargrove et al. (24), respectively.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   The observed rate (kobs) dependence of the O2 concentration for the O2 reaction with the ferrous heme-HO complex after the flash photolysis measured in 0.1 M phosphate buffer, pH 7, measured at 20 °C.

The CO association reactions of both the HO-1 and HO-2 heme complexes are biphasic with the faster phase showing a bimolecular rate that is about 4~5 times larger than that of the slower phase. The amplitudes of the two phases are independent of CO concentrations (between 0.1 and 1 mM). The association rate constants, k'CO, for the slower phases are between 0.3 and 0.6 µM-1 s-1, which are similar to those of myoglobin (0.5-0.8 µM-1 s-1) (22). The kinetic traces for CO dissociation from the heme-HO complexes are monophasic. The dissociation rate constants, kCO, (0.007-0.009 s-1) are slightly smaller than those of myoglobin (~0.02 s-1) (22). Because of the biphasic nature of the CO association reactions, the overall CO equilibrium association constants, KCO, can only be estimated as between 34 and 150 µM-1 and 89 and 420 µM-1 for the HO-1 and HO-2 complexes, respectively. It should be noted that the ratios of CO and O2 affinities, KCO/KO2, are between 1.2 and 5.6 for the heme-HO complex. These ratios are much smaller than those for myoglobin (~40) and hemoglobin (~200) (23). Thus, O2 binding to the ferrous heme iron in HO is inhibited to a much lesser extent by CO than it is in myoglobin and hemoglobin.

The reaction of CO with the ferrous alpha -hydroxyheme-HO-1 complex is also biphasic (Table II), and the association rate constants for the fast and slow phases are similar to those of the heme-HO-1 complex. Again, CO dissociation is monophasic, and the dissociation rate constant is essentially the same as that of the heme-HO complex. Thus, the hydroxyl group at the alpha -meso position does not affect the reactivity of the ferrous iron toward CO. The oxy form of the alpha -hydroxyheme-HO complex is unstable (17) and cannot be prepared for O2 binding and dissociation rate measurements.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Parameters for CO binding to the alpha -hydroxyheme- and verdoheme-HO complexes in 0.1 M phosphate, pH 7, 20 °C
Data for the verdoheme-myolobin complex are taken from Fujii (20).

The reaction of CO with verdoheme-HO complexes is different from that of the heme- and alpha -hydroxyheme-HO complexes. The rebinding reaction is monophasic after flash photolysis. Plots of the dependence of the observed pseudo-first order rate constant, kobs, on CO concentration are shown in Fig. 2A for the verdoheme-HO-1 complex. The slope and the y axis intercept of this plot yield association and dissociation rate constants equal to 0.0054 µM-1 s-1 and 2.9 s-1, respectively, and a CO equilibrium association constant equal to 0.0018 µM-1. Thus, the CO affinity of the verdoheme-HO-1 is more than 10,000 times weaker than that of the protoheme complex (Table II). Low CO affinity is confirmed by the CO equilibrium curve generated by plotting the absorption changes induced by the flash photolysis as a function of the CO concentration (Fig. 2B). Because the quantum yield of the CO form of the verdoheme-HO complex is almost 1 (15), the absorption changes after photolysis are proportional to the equilibrium fraction degree of saturation with this ligand. The experimental points are compared with a CO equilibrium curve calculated from the association and dissociation rate constants. The agreement between the calculated and observed results is excellent. The verdoheme HO-2 complex has the CO binding parameters similar to those of the corresponding HO-1 complex. As in the case of alpha -hydroxyheme-HO, an oxy form of the verdoheme-HO complex cannot be obtained for kinetic measurements. Verdoheme-myoglobin also shows a large CO dissociation rate, but the association rate and equilibrium constants of the myoglobin complex are about 10 times greater than those of the HO complex (20) (Table II).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Panel A, observed rate (kobs) dependence of the CO concentration for the CO reaction with the verdoheme-HO complex after the flash photolysis measured in 0.1 M phosphate buffer, pH 7. Panel B, absorbance changes at 636 nm induced by the flash photolysis of the CO-bound verdoheme-HO complexes. The squares are experimental data points, and the curve is calculated from the equilibrium association constant derived from the kinetic parameters (Table II). The measurements were carried out at 20 °C.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The oxygen equilibrium constants, 30-80 µM-1, of the heme-HO complex are similar to those of leghemoglobin (23 µM-1) (24). However, the mechanism responsible for the extraordinarily high O2 affinity for the heme-HO complex is different from that for leghemoglobin. The high O2 affinity of leghemoglobin is caused by a very large association rate constant that is determined by enhanced reactivity of the heme iron toward O2 (24). In the heme-HO complex, high O2 affinity is caused by a very slow O2 dissociation rate constant. Decreases in O2 dissociation rate constants for myoglobins and related heme proteins are associated with increases in hydrogen bonding or other favorable electrostatic interactions between bound oxygen and surrounding amino acids. For example, replacing the distal valine [E11] with an asparagine residue in sperm whale myoglobin decreases kO2 from 15 s-1 to 0.5 s-1 presumably by creating a second hydrogen bond with the bound ligand (22). The presence of strong interactions between distal residues in heme oxygenase and bound O2 has already been proposed based on resonance Raman studies (14) and on cobalt EPR work (25).

The CO association reactions with the heme- and alpha -hydroxyheme-HO complexes are biphasic. One of the possible origins of the biphasic reaction is heme orientational disorder around the porphyrin alpha -gamma axis, which has been reported for the heme-HO complex (26). However, if this were the case, the O2 association reaction would also be expected to be biphasic, but this is not the case. In addition, the ligand binding properties of myoglobin are independent of the heme orientation disorder (27). Thus, the structural origin of the biphasic CO association reactions with the heme- and alpha -hydroxyheme-HO complex is not clear.

There are subtle differences in the kinetic parameters between the HO-1 and HO-2 complexes. The neutral imidazole form of histidine is the proximal ligand in both isoforms (8-10). In the hemin-enzyme complex, the pKa value of the acid-base transition of the HO-1 complex (pKa 7.6) is 0.9 unit lower than that in the HO-2 complex (pKa 8.5) (8, 9). Thus, the polarities of the distal pockets appear to be different between the isoforms, which might explain the small difference in kinetic parameters.

As shown in Scheme 2, alpha -hydroxyheme undergoes a redox-linked transition between ferric oxophlorin and ferrous alpha -hydroxyheme (17). In the ferrous form, the prosthetic group assumes a porphyrin macrocycle structure with a hydroxyl group at the alpha -meso position (structure 2 of Scheme 2). The alpha -hydroxyl group should be electron-donating, and electron withdrawal or electron donation from heme side chains has been shown to affect the reactivity of the heme iron (23, 28). However, the CO binding properties of the alpha -hydroxyheme-HO complex are similar to those of the heme complex, indicating that the alpha -meso hydroxyl group does not affect either heme iron reactivity or iron-CO bond strength. The porphyrin pi -electron spin density at the alpha -meso carbon could be so low that the electron donation at this position does not affect the iron reactivity appreciably. The Raman results show that the Fe-CO and C-O stretching frequencies of the CO-bound alpha -hydroxyheme-HO complex are similar to those of the heme-HO complex (15). This implies that the electronic states of the Fe-CO unit and the Fe-C bond strengths are similar in these complexes, which is consistent with our kinetic results.


View larger version (24K):
[in this window]
[in a new window]
 
Scheme 2.   Top, the iron redox state-linked conversion between ferric oxophlorin (structure 1) and ferrous hydroxyheme (structure 2) (17). Bottom, two alternative verdoheme structures (structures 3 and 4) derived from Ref. 29.

In the verdoheme-HO complex the iron atom is less reactive, and the iron-CO bond is much weaker than that in the heme and alpha -hydroxyheme-HO complexes. Two resonance structures have been suggested for verdoheme and are shown in Scheme 2 (29). Structure 4 possesses a positive charge on the ring oxygen atom, whereas the charge is on the iron atom in structure 3. The resonance Raman studies show that a significant contribution from structure 3 is present in ferrous verdoheme-HO (15). Because CO binds only to ferrous iron, the presence of a significant amount of a ferric character will reduce the reactivity of verdoheme-HO toward CO significantly.

The Fe-CO stretching frequency of the CO verdoheme-HO complex is 474 cm-1, whereas those for the heme- and alpha -hydroxyheme-HO complexes are 503 and 508 cm-1, respectively (10, 15). Clearly, the Fe-CO bond order in verdoheme-HO is lower than that in the heme- and alpha -hydroxyheme complexes. Because the rate of CO dissociation is determined by the rate of the thermal Fe-CO bond breakage (30), the lower Fe-CO bond order is probably the cause of the large kCO value shown by verdoheme-HO.

The conversion of alpha -hydroxyheme to verdoheme by HO generates CO stoichiometrically (16). Yoshida and co-workers (16, 18) have shown that CO can inhibit the mono-oxygenation reactions of the HO catalytic cycle by binding to the ferrous heme- or verdoheme-HO complex. Hence, CO could potentially act as a product inhibitor. When catalysis is carried out in air-saturated buffer, hemin is stoichiometrically converted to biliverdin, and the product inhibition by CO does not appear to occur. The results in Tables I and II explain why the CO produced does not severely inhibit heme oxygenase activity. The first oxygenation cycle is not inhibited because the ferrous iron atom in protoheme-HO has an extremely high affinity for O2 which is roughly equal to that for CO. In air, the concentration of O2 will always be much greater than that of CO, preventing product inhibition. When alpha -hydroxyheme is converted to verdoheme in HO, the CO molecule generated by oxygenation of the heme group could also bind to the verdoheme product. In this case, CO binding to the verdoheme-HO complex is extremely weak, and the CO dissociation rate constant is very large, preventing product inhibition until the CO concentration is greater than 0.5 atmospheres or 500 µM. Previous experimental work has also shown that CO does not inhibit the conversion of alpha -hydroxyheme to verdoheme (17, 18). Thus, the active site of HO has evolved to discriminate strongly against CO binding and in favor of the binding of O2, which is the oxidizing substrate for the overall reaction.

    FOOTNOTES

* This work was supported in part by United States Public Health Service Grants GM35649 and HL47020 (to J. S. O.) and GM51588 (to M. I.-S.); Robert A. Welch Foundation Grant C-612 (to J. S. O.); Grants-in-aid for Scientific Research 08044240, 08249101, 08680675, and 09235101 (to T. Y.); and Grants 09235236 and 09740504 from the Ministry of Education, Science, Sports, and Culture, Japan (to H. F.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Permanent address: School of Allied Health Sciences, Yamaguchi University, Ube, Yamaguchi 755, Japan.

§ Present address: Dept. of Chemistry, Baldwin-Wallace College, Berea, OH 44017.

To whom correspondence should be addressed.

1 The abbreviation used is: HO, heme oxygenase.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Tenhunen, R., Marver, H. S., and Schmid, R. (1969) J. Biol. Chem. 244, 6388-6394[Abstract/Free Full Text]
  2. Kikuchi, G., and Yoshida, T. (1980) Trends Biochem. Sci. 5, 323-325
  3. Maines, M. D. (1988) FASEB J. 2, 2557-2568[Abstract/Free Full Text]
  4. Yoshida, T., and Kikuchi, G. (1978) J. Biol. Chem. 253, 4224-4229[Medline] [Order article via Infotrieve]
  5. Yoshida, T., and Kikuchi, G. (1979) J. Biol. Chem. 254, 4487-4491[Abstract]
  6. Yoshida, T., Noguchi, M., and Kikuchi, G. (1980) J. Biol. Chem. 255, 4418-4420[Free Full Text]
  7. Yoshida, T., and Kikuchi, G. (1978) J. Biol. Chem. 253, 4230-4236[Medline] [Order article via Infotrieve]
  8. Ishikawa, K., Takeuchi, N., Takahashi, S., Matera, K. M., Sato, M., Shibahara, S., Rousseau, D. L., Ikeda-Saito, M., Yoshida, T. (1995) J. Biol. Chem. 270, 6345-6350[Abstract/Free Full Text]
  9. Takahashi, S., Wang, J., Rousseau, D. L., Ishikawa, K., Yoshida, T., Host, J. R., Ikeda-Saito, M. (1994) J. Biol. Chem. 269, 1010-1014[Abstract/Free Full Text]
  10. Takahashi, S., Wang, J., Rousseau, D. L., Ishikawa, K., Yoshida, T., Takeuchi, N., Ikeda-Saito, M. (1994) Biochemistry 33, 5531-5538[Medline] [Order article via Infotrieve]
  11. Ito-Maki, M., Ishikawa, K., Mansfield Matera, K., Sato, M., Ikeda-Saito, M., Yoshida, T. (1995) Arch. Biochem. Biophys. 317, 253-258[CrossRef][Medline] [Order article via Infotrieve]
  12. Sun, J., Loehr, T. M., Wilks, A., and Ortiz de Montellano, P. R. (1994) Biochemistry 33, 13734-13740[Medline] [Order article via Infotrieve]
  13. Mansfield Matera, K., Zhou, H., Migita, C. T., Hobert, S. E., Ishikawa, K., Katakura, K., Maeshima, H., Yoshida, T., Ikeda-Saito, M. (1997) Biochemistry 36, 4909-4915[CrossRef][Medline] [Order article via Infotrieve]
  14. Takahashi, S., Ishikawa, K., Takeuchi, N., Ikeda-Saito, M., Yoshida, T., and Rousseau, D. L. (1995) J. Am. Chem. Soc. 117, 6002-6006
  15. Takahashi, S., Mansfield Matera, K., Fujii, H., Zhou, H., Ishikawa, K., Yoshida, T., Ikeda-Saito, M., and Rousseau, D. L. (1997) Biochemistry 36, 1402-1410[CrossRef][Medline] [Order article via Infotrieve]
  16. Yoshida, T., Noguchi, M., and Kikuchi, G. (1982) J. Biol. Chem. 257, 9345-9348[Free Full Text]
  17. Matera, K., Takahashi, S., Fujii, H., Zhou, H., Ishikawa, K., Yoshimura, T., Rousseau, D. L., Yoshida, T., Ikeda-Saito, M. (1996) J. Biol. Chem. 271, 6618-6624[Abstract/Free Full Text]
  18. Noguchi, M., Yoshida, T., and Kikuchi, G. (1981) J. Biochem. (Tokyo) 90, 1671-1675[Abstract]
  19. Yoshida, T., Noguchi, M., and Kikuchi, G. (1980) J. Biochem. (Tokyo) 88, 557-563[Medline] [Order article via Infotrieve]
  20. Fujii, H. (1990) Studies on the Electronic Structure and Reactivities of Catalytic Intermediates in Heme EnzymesPh.D. thesis, Kyoto University, Kyoto, Japan
  21. Rohlfs, R. J., Mathews, A. J., Carver, T. E., Olson, J. S., Springer, B. A., Egeberg, K. D., Sligar, S. G. (1990) J. Biol. Chem. 265, 3168-3176[Abstract/Free Full Text]
  22. Springer, B. A., Sligar, S. G., Olson, J. S., Phillips, G. N., Jr. (1994) Chem. Rev. 94, 699-714
  23. Antonini, E., and Brunori, M. (1971) Hemoglobins and Myoglobins and Their Reactions with Ligands, North Holland Publishing Co., Amsterdam
  24. Hargrove, M. S., Barry, J. K., Brucker, E. A., Berry, M. B., Phillips, G. N., Jr., Olson, J. S., Arredondo-Peter, R., Dean, J. M., Klucas, R. V., Srath, G. (1997) J. Mol. Biol. 266, 1032-1042[CrossRef][Medline] [Order article via Infotrieve]
  25. Ikeda-Saito, M., Fujii, H., Mansfield Matera, M., Takahashi, S., Migita, C. T., Rousseau, D. L., Yoshida, T. (1998) in Oxygen Homeostasis and Dynamics (Ishimura, Y., Shimada, H., and Suematsu, M., eds), pp. 304-314, Springer-Velag, Tokyo
  26. Hernandez, G., Wilks, A., Paoless, R., Smith, K. M., Ortiz de Montellano, P. R., La Mar, G. N. (1994) Biochemistry 33, 6631-6641[Medline] [Order article via Infotrieve]
  27. Light, W. R., Rohlfs, R. J., Palmer, G., and Olson, J. S. (1987) J. Biol. Chem. 262, 46-52[Abstract/Free Full Text]
  28. Sono, M., Smith, P. D., McCray, J. A., Asakura, T. (1976) J. Biol. Chem. 251, 1418-1426[Abstract]
  29. Balch, A. L., Latos-Grazynski, L., Noll, B. C., Olmstead, M. M., Szterenberg, L., Safari, N. (1993) J. Am. Chem. Soc. 115, 1422-1429
  30. Carver, T. E., Rohlfs, R. J., Olson, J. S., Gibson, Q. H., Blackmore, R. S., Springer, B. A., Sligar, S. G. (1990) J. Biol. Chem. 265, 20007-20020[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.